EDGAR·FLOW

60 DEGREES PHARMACEUTICALS, INC. — Form 8-K

Filed November 20, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 92/100
What the filing says
On 2026-11-19, 60 Degrees Pharmaceuticals received notice of failure to satisfy continued listing standards (Item 3.01). The specific listing rule violation, cure period, and any transfer of listing details are not disclosed in the filing header or accessible document summary provided. The company's market capitalization is approximately $3.3M.
Why this rating

Delisting is existential threat for $3.3M company; loss of exchange listing severely impairs capital access, trading liquidity, and investor confidence.

Extracted items
Price action (we called it negative)
at our read
pending
+10 min
pending
+30 min
pending
+1 hr
pending
+4 hrs
pending

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ SXTPW · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.